all Chad Cowan stories

Efficiency of producing iPS cells markedly improved

404132862 — Wed, 10 Sep 2008 14:55:30 -0400

Some of the most challenging obstacles limiting the reprogramming of mature human cells into stem cells may not seem quite as daunting in the near future. Two independent research groups, one lead by Harvard Stem Cell Institute Principal Faculty member Konrad Hochedlinger, and another at the Whitehead Institute, are describing new tools that provide invaluable platforms for elucidating the molecular, genetic and biochemical mechanisms associated with reprogramming.

Daley and colleagues create 20 disease-specific stem cell lines

404132862 — Tue, 05 Aug 2008 10:48:17 -0400

Harvard Stem Cell Institute researcher George Q.

GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement

404132862 — Mon, 21 Jul 2008 15:00:05 -0400

GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.

Reprogrammed adult skin cells treat Parkinson's disease in animal model

404132862 — Thu, 10 Apr 2008 16:01:23 -0400

Researchers at the Whitehead Institute and Harvard Stem Cell Institute(HSCI) have reported successfully reducing symptoms in a Parkinson's disease rat model by using dopamine producing neurons derived from reprogrammed adult skin cells(iPS).

The work was reported in a study published in the online Early Edition of Proceedings of the National Academy of Science.

Adult cells transformed into stem cells

70652986 — Mon, 26 Mar 2007 06:22:02 -0400

Harvard researchers fused adult skin cells with embryonic stem cells in such a way that the genes of the embryonic cells reset the genetic clock of the adult cells, turning them back to their embryonic form.

Such adult-cum-embryo cells, taken from people with juvenile diabetes, Parkinson's, Alzheimer's, and other genetic diseases, could reveal how such diseases develop and provide novel treatments for them. For example, normal cells might be made to replace abnormal ones that cause juvenile diabetes and Alzheimer's disease. It should be possible to coax these newly created embryonic cells "into replacement cells and even organs," says biologist Chad Cowan who participated in the experiments. "But it would definitely not be possible to clone the person from which the adult cell came."

Cowan is the lead author of a report of the research published in the Aug. 26 issue of Science. The other authors are Kevin Eggan, Douglas Melton, and Jocelyn Atienza of the Harvard Stem Cell Institute.